Your email has been successfully added to our mailing list.

×
0 0.0105721393034826 0.0105721393034826 0.0105721393034826 -0.00886194029850735 0.000855099502487641 0.0105721393034826 0.0105721393034826
Stock impact report

Leading PBM adds BioDelivery's Belbuca to formulary [Seeking Alpha]

BioDelivery Sciences International, Inc. (BDSI) 
Last biodelivery sciences international, inc. earnings: 11/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bdsi.com/news-events/news-releases
Company Research Source: Seeking Alpha
BioDelivery Sciences ( BDSI ) announces that an unnamed U.S. pharmacy benefit manager (PBM) has added pain med BELBUCA (buprenorphine) buccal film to its national preferred formulary effective today. The PBM serves over 20M covered lives. Click to subscribe to real-time analytics on BDSI Now read: Updated Investment Case On BioDelivery Sciences » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
BDSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BDSI alerts
Opt-in for
BDSI alerts

from News Quantified
Opt-in for
BDSI alerts

from News Quantified